Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension

Jason M. Golbin, Virend Somers, Sean M. Caples

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

With the growing epidemic of obesity in an aging population, obstructive sleep apnea (OSA) is increasingly encountered in clinical practice. Given the acute cardiopulmonary stressors consequent to repetitive upper airway collapse, as well as evidence for cardiovascular homeostatic dysregulation in subjects with sleep apnea, there is ample biologic plausibility that OSA imparts increased cardiovascular risk, independent of comorbid disease. Indeed, observational studies have suggested strong associations with multiple disorders, such as systemic hypertension, heart failure, cardiac arrhythmias, and pulmonary hypertension. Further data in the form of longitudinal cohort studies and randomized controlled trials are accruing to add to the body of evidence. This review examines pathophysiologic mechanisms and explores current concepts regarding the impact of OSA and its treatment on selected clinical disease states.

Original languageEnglish (US)
Pages (from-to)200-206
Number of pages7
JournalProceedings of the American Thoracic Society
Volume5
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Obstructive Sleep Apnea
Pulmonary Hypertension
Cardiovascular Diseases
Sleep Apnea Syndromes
Observational Studies
Longitudinal Studies
Cardiac Arrhythmias
Cohort Studies
Randomized Controlled Trials
Heart Failure
Obesity
Hypertension
Population

Keywords

  • Arrhythmia
  • Positive airway pressure
  • Sleep-disordered breathing
  • Stroke

ASJC Scopus subject areas

  • Cell Biology
  • Physiology
  • Pulmonary and Respiratory Medicine

Cite this

Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension. / Golbin, Jason M.; Somers, Virend; Caples, Sean M.

In: Proceedings of the American Thoracic Society, Vol. 5, No. 2, 02.2008, p. 200-206.

Research output: Contribution to journalArticle

@article{260563d576d34f188734d45da7843c6d,
title = "Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension",
abstract = "With the growing epidemic of obesity in an aging population, obstructive sleep apnea (OSA) is increasingly encountered in clinical practice. Given the acute cardiopulmonary stressors consequent to repetitive upper airway collapse, as well as evidence for cardiovascular homeostatic dysregulation in subjects with sleep apnea, there is ample biologic plausibility that OSA imparts increased cardiovascular risk, independent of comorbid disease. Indeed, observational studies have suggested strong associations with multiple disorders, such as systemic hypertension, heart failure, cardiac arrhythmias, and pulmonary hypertension. Further data in the form of longitudinal cohort studies and randomized controlled trials are accruing to add to the body of evidence. This review examines pathophysiologic mechanisms and explores current concepts regarding the impact of OSA and its treatment on selected clinical disease states.",
keywords = "Arrhythmia, Positive airway pressure, Sleep-disordered breathing, Stroke",
author = "Golbin, {Jason M.} and Virend Somers and Caples, {Sean M.}",
year = "2008",
month = "2",
doi = "10.1513/pats.200708-143MG",
language = "English (US)",
volume = "5",
pages = "200--206",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension

AU - Golbin, Jason M.

AU - Somers, Virend

AU - Caples, Sean M.

PY - 2008/2

Y1 - 2008/2

N2 - With the growing epidemic of obesity in an aging population, obstructive sleep apnea (OSA) is increasingly encountered in clinical practice. Given the acute cardiopulmonary stressors consequent to repetitive upper airway collapse, as well as evidence for cardiovascular homeostatic dysregulation in subjects with sleep apnea, there is ample biologic plausibility that OSA imparts increased cardiovascular risk, independent of comorbid disease. Indeed, observational studies have suggested strong associations with multiple disorders, such as systemic hypertension, heart failure, cardiac arrhythmias, and pulmonary hypertension. Further data in the form of longitudinal cohort studies and randomized controlled trials are accruing to add to the body of evidence. This review examines pathophysiologic mechanisms and explores current concepts regarding the impact of OSA and its treatment on selected clinical disease states.

AB - With the growing epidemic of obesity in an aging population, obstructive sleep apnea (OSA) is increasingly encountered in clinical practice. Given the acute cardiopulmonary stressors consequent to repetitive upper airway collapse, as well as evidence for cardiovascular homeostatic dysregulation in subjects with sleep apnea, there is ample biologic plausibility that OSA imparts increased cardiovascular risk, independent of comorbid disease. Indeed, observational studies have suggested strong associations with multiple disorders, such as systemic hypertension, heart failure, cardiac arrhythmias, and pulmonary hypertension. Further data in the form of longitudinal cohort studies and randomized controlled trials are accruing to add to the body of evidence. This review examines pathophysiologic mechanisms and explores current concepts regarding the impact of OSA and its treatment on selected clinical disease states.

KW - Arrhythmia

KW - Positive airway pressure

KW - Sleep-disordered breathing

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=39049087089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049087089&partnerID=8YFLogxK

U2 - 10.1513/pats.200708-143MG

DO - 10.1513/pats.200708-143MG

M3 - Article

C2 - 18250213

AN - SCOPUS:39049087089

VL - 5

SP - 200

EP - 206

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 2

ER -